What Is Aging in Humans
Aging in humans is the gradual decline in physiological function that increases vulnerability to disease and death. It involves cellular damage, telomere shortening, and altered gene expression. The World Health Organization defines aging as the accumulation of molecular and cellular damage over time, which reduces functional capacity and increases disease risk. This biological process interacts with lifestyle, environment, and genetics to shape individual health trajectories.
Global average life expectancy at birth reached about 73 years according to the latest WHO estimates, with wide variation across countries. Japan, Switzerland, and Singapore consistently rank among the top nations for longevity, while sub-Saharan Africa lags behind due to infectious disease burdens and limited healthcare access. The United Nations projects the proportion of people aged 65 and older will rise sharply in the coming decades, reshaping labor markets, pension systems, and public budgets.
Key Biological Mechanisms of Aging
Researchers identify several core hallmarks of aging, including genomic instability, epigenetic alterations, loss of proteostasis, and mitochondrial dysfunction. These mechanisms drive tissue deterioration and chronic disease. The National Institute on Aging funds studies that link these hallmarks to conditions such as cardiovascular disease, cancer, and neurodegeneration.
Senescence, the state in which cells stop dividing but remain metabolically active, is a major driver of age-related decline. Senescent cells secrete inflammatory molecules that damage surrounding tissue, a process called the senescence-associated secretory phenotype. Companies such as Unity Biotechnology are developing senolytic drugs designed to clear these cells, with clinical trials targeting osteoarthritis and pulmonary fibrosis.
Societal and Economic Impact of Aging
Aging populations strain public finances through higher healthcare spending and pension obligations. The U.S. Social Security Administration reports that the ratio of workers to beneficiaries has fallen sharply, pressuring the system's solvency. The Congressional Budget Office projects that spending on Social Security and Medicare will grow significantly as a share of GDP over the next three decades.
Private-sector innovation is addressing longevity and elder care. Fidelity Investments estimates that a 65-year-old couple retiring in 2024 will need about $315,000 in healthcare savings, excluding long-term care. Firms like Intuitive Surgical and Medtronic are expanding robotic and minimally invasive surgical tools for older patients, while insurers such as UnitedHealth Group are developing predictive analytics models to manage age-related risk pools more efficiently.